Persistent Candiduria Complicating Intraureteral Stenting a Case Report and Review of Literature
1. Rivett AG, Perry JA, Cohen J. Urinary candidiasis: a prospective study in hospital patients. Urol Res. 1986; xiv:183–186.
2. Hamory BH, Wenzel RP. Hospital-associated candiduria: predisposing factors and review of the literature. J Urol. 1978; 120:444–448.
3. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis. 2000; thirty:xiv–18.
4. Ayeni O, Riederer KM, Wilson FM, Khatib R. Clinicians' reaction to positive urine culture for Candida organisms. Mycoses. 1999; 42:285–289.
5. Storfer SP, Medoff G, Fraser VJ, Powderly WG, Dunagan WC. Candiduria: retrospective review in hospitalized patients. Infect Dis Clin Pract. 1994; 3:23–29.
6. Harris AD, Castro J, Sheppard DC, Carmeli Y, Samore MH. Adventure factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin Infect Dis. 1999; 29:926–928.
7. Jacobs LG. Fungal urinary tract infections in the elderly: treatment guidelines. Drugs Aging. 1996; eight:89–96.
8. Kauffman CA. Fungal infections in older adults. Clin Infect Dis. 2001; 33:550–555.
9. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public wellness trouble. Clin Microbiol Rev. 2007; 20:133–163.
x. Dimopoulos Chiliad, Paiva JA, Meersseman Westward, Pachl J, Grigoras I, Sganga G, et al. Efficacy and safety of anidulafungin in elderly, critically sick patients with invasive Candida infections: a post hoc analysis. Int J Antimicrob Agents. 2012; xl:521–526.
xi. Flevari A, Theodorakopoulou M, Velegraki A, Armaganidis A, Dimopoulos G. Treatment of invasive candidiasis in the elderly: a review. Clin Interv Aging. 2013; 8:1199–1208.
12. Bouza E, San Juan R, Munoz P, Voss A, Kluytmans J. Cooperative Grouping of the European Report Group on Nosocomial Infections. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect. 2001; 7:523–531.
thirteen. Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections--epidemiology. Clin Infect Dis. 2011; 52 Suppl 6:S433–S436.
fourteen. Kobayashi CC, de Fernandes OF, Miranda KC, de Sousa ED, Silva Mdo R. Candiduria in hospital patients: a study prospective. Mycopathologia. 2004; 158:49–52.
15. Safdar N, Slattery WR, Knasinski V, Gangnon RE, Li Z, Pirsch JD, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis. 2005; xl:1413–1421.
xvi. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996; 100:617–623.
17. Malani PN, Bradley SF, Trivial RS, Kauffman CA. Trends in species causing fungaemia in a third intendance medical centre over 12 years. Mycoses. 2001; 44:446–449.
18. Pfaller MA, Diekema DJ. Part of lookout surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol. 2002; 40:3551–3557.
19. Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ. SENTRY Participants Grouping. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol. 2002; 40:852–856.
twenty. Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014; 20 Suppl 6:v–x.
21. Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: experience in a 3rd intendance center. Clin Infect Dis. 2005; 41:975–981.
22. Phillips JR, Karlowicz MG. Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr Infect Dis J. 1997; 16:190–194.
23. Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin Northward Am. 2014; 28:61–74.
24. Hof H, Mikus K. [Candida infections in the elderly]. Z Gerontol Geriatr. 2013; 46:64–70. German.
25. Aw D, Silva AB, Palmer DB. Is thymocyte development functional in the aged? Aging (Albany NY). 2009; ane:146–153.
26. Colonna-Romano G, Buffa S, Bulati M, Candore M, Lio D, Pellicanò M, et al. B cells compartment in centenarian offspring and one-time people. Curr Pharm Des. 2010; 16:604–608.
27. Deray Thou. Amphotericin B nephrotoxicity. J Antimicrob Chemother. 2002; 49 Suppl one:37–41.
28. Stine JG, Sateesh P, Lewis JH. Drug-induced liver injury in the elderly. Curr Gastroenterol Rep. 2013; 15:299.
29. Woodhouse G, Wynne HA. Age-related changes in hepatic function. Implications for drug therapy. Drugs Crumbling. 1992; 2:243–255.
30. Tulner LR, Kuper IM, Frankfort SV, van Campen JP, Koks CH, Brandjes DP, et al. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drugdrug interactions. Am J Geriatr Pharmacother. 2009; 7:93–104.
31. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003; 163:2716–2724.
32. Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007; 32:113–121.
33. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Gamble factors for hospital-caused candidemia. A matched instance-control written report. Curvation Intern Med. 1989; 149:2349–2353.
34. Fisher JF, Kavanagh G, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011; 52 Suppl 6:S437–S451.
35. MacCallum DM, Odds FC. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses. 2005; 48:151–161.
36. Kauffman CA. Candiduria. Clin Infect Dis. 2005; 41 Suppl half dozen:S371–S376.
37. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010; 23:253–273.
38. Siddique MS, Gayed N, McGuire N, Khatilb R. Salient features of Candida pyelonephritis in adults. Infect Dis Clin Pract. 1992; 1:240–245.
39. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000; 160:678–682.
forty. You JH, Kim MK. Bacterial urosepsis by a fungal ball mimicking a ureteral stone. Korean J Urogenit Tract Infect Inflamm. 2014; 9:115–118.
41. Jacobs LG, Skidmore EA, Cardoso LA, Ziv F. Float irrigation with amphotericin B for handling of fungal urinary tract infections. Clin Infect Dis. 1994; 18:313–318.
42. Fisher JF, Newman CL, Sobel JD. Yeast in the urine: solutions for a budding problem. Clin Infect Dis. 1995; 20:183–189.
43. Bougnoux ME, Kac Yard, Aegerter P, d'Enfert C, Fagon JY. CandiRea Report Group. Candidemia and candiduria in critically ill patients admitted to intensive intendance units in France: incidence, molecular diversity, management and outcome. Intensive Care Med. 2008; 34:292–299.
44. Drogari-Apiranthitou M, Anyfantis I, Galani I, Kanioura L, Daikos GL, Petrikkos G. Association betwixt candiduria and candidemia: a clinical and molecular analysis of cases. Mycopathologia. 2017; 182:1045–1052.
45. Sobel JD, Kauffman CA, McKinsey D, Zervos M, Vazquez JA, Karchmer AW, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. Clin Infect Dis. 2000; 30:19–24.
46. Ang BS, Telenti A, Rex B, Steckelberg JM, Wilson WR. Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis. 1993; 17:662–666.
47. Gross K, Winkler H, Pitlik South, Weinberger One thousand. Unexpected candidemia complicating ureteroscopy and urinary stenting. Eur J Clin Microbiol Infect Dis. 1998; 17:583–586.
48. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Lodge of America. Clin Infect Dis. 2009; 48:503–535.
49. Yang And then. Catheter-associated urinary tract infection. Korean J Urogenit Tract Infect Inflamm. 2013; eight:73–82.
50. Auger P, Dumas C, Joly J. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine. J Infect Dis. 1979; 139:590–594.
51. Fisher JF, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infections--handling. Clin Infect Dis. 2011; 52 Suppl 6:S457–S466.
52. Goldman HJ, Littman ML, Oppenheimer GD, Glickman SI. Monilial cystitis-effective handling with instilations of amphotericin B. JAMA. 1960; 174:359–362.
53. Drew RH, Arthur RR, Perfect JR. Is it time to carelessness the utilize of amphotericin B bladder irrigation? Clin Infect Dis. 2005; 40:1465–1470.
54. Agustin J, Lacson S, Raffalli J, Aguero-Rosenfeld ME, Wormser GP. Failure of a lipid amphotericin B preparation to eradicate candiduria: preliminary findings based on three cases. Clin Infect Dis. 1999; 29:686–687.
55. Wise GJ, Shteynshlyuger A. How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep. 2006; seven:320–328.
56. Bartkowski DP, Lanesky JR. Emphysematous prostatitis and cystitis secondary to Candida albicans. J Urol. 1988; 139:1063–1065.
57. Giannopoulos A, Giamarellos-Bourboulis EJ, Adamakis I, Georgopoulou I, Petrikkos G, Katsilambros Northward. Epididymitis caused past Candida glabrata: a novel infection in diabetic patients? Diabetes Care. 2001; 24:2003–2004.
58. Jenkin GA, Choo M, Hosking P, Johnson PD. Candidal epididymoorchitis: example study and review. Clin Infect Dis. 1998; 26:942–945.
59. Fisher J, Mayhall K, Duma R, Shadomy S, Shadomy J, Watlington C. Fungus balls of the urinary tract. South Med J. 1979; 72:1281–1284. 1287
60. Chung BH, Chang SY, Kim SI, Choi HS. Successfully treated renal fungal ball with continuous irrigation of fluconazole. J Urol. 2001; 166:1835–1836.
61. Bartone FF, Hurwitz RS, Rojas EL, Steinberg Due east, Franceschini R. The office of percutaneous nephrostomy in the management of obstructing candidiasis of the urinary tract in infants. J Urol. 1988; 140:338–341.
62. Chitale SV, Shaida Due north, Burtt One thousand, Burgess N. Endoscopic management of renal candidiasis. J Endourol. 2004; 18:865–866.
63. Kabaalioğlu A, Bahat E, Boneval C. Renal candidiasis in a 2-calendar month-old babe: treatment of mucus assurance with streptokinase. AJR Am J Roentgenol. 2001; 176:511–512.
64. Fisher JF, Woeltje 1000, Espinel-Ingroff A, Stanfield J, DiPiro JT. Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience. Clin Microbiol Infect. 2003; 9:1024–1027.
Source: https://synapse.koreamed.org/articles/1135035
0 Response to "Persistent Candiduria Complicating Intraureteral Stenting a Case Report and Review of Literature"
Post a Comment